Loxam Teri has filed 29 insider transactions across 2 companies since March 2024.
Most recent transaction: a grant/award of 157635 shares of COMPASS Pathways plc ($CMPS) on March 26, 2026.
Activity breakdown: 0 open-market purchases and 12 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | COMPASS Pathways plc | $CMPS | Loxam Teri | Chief Financial Officer | A | Share Option (Right to Buy) | 157635 | $0.00 | 157,635.0000 | 96,017,044 | 9999.99% | 0.16% |
| March 26, 2026 | COMPASS Pathways plc | $CMPS | Loxam Teri | Chief Financial Officer | A | Ordinary Shares | 75000 | $0.00 | 152,002.0000 | 96,017,044 | 97.40% | 0.08% |
| March 11, 2026 | COMPASS Pathways plc | $CMPS | Loxam Teri | Chief Financial Officer | F | Ordinary Shares | 1781 | $6.89 | 77,002.0000 | 96,017,044 | 2.26% | 0.00% |
| March 2, 2026 | COMPASS Pathways plc | $CMPS | Loxam Teri | Chief Financial Officer | F | Ordinary Shares | 4467 | $7.02 | 78,783.0000 | 96,017,044 | 5.37% | 0.00% |
| June 12, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | A | Common Stock | 3041 | $0.00 | 10,216.0000 | 121,997,348 | 42.38% | 0.00% |
| June 12, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | A | Stock Option (right to buy) | 15372 | $0.00 | 15,372.0000 | 121,997,348 | 9999.99% | 0.01% |
| March 11, 2025 | COMPASS Pathways plc | $CMPS | Loxam Teri | Chief Financial Officer | A | Share Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 92,673,132 | 9999.99% | 0.08% |
| March 11, 2025 | COMPASS Pathways plc | $CMPS | Loxam Teri | Chief Financial Officer | A | Ordinary Shares | 25000 | $0.00 | 83,250.0000 | 92,673,132 | 42.92% | 0.03% |
| March 3, 2025 | COMPASS Pathways plc | $CMPS | Loxam Teri | Chief Financial Officer | F | Ordinary Shares | 4468 | $3.67 | 58,250.0000 | 92,673,132 | 7.12% | 0.00% |
| Jan. 15, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 1013 | $87.38 | 7,704.0000 | 121,997,348 | 11.62% | 0.00% |
| Jan. 15, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 529 | $88.54 | 7,175.0000 | 121,997,348 | 6.87% | 0.00% |
| Jan. 15, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | M | Stock Option (right to buy) | 6250 | $0.00 | 6,250.0000 | 121,997,348 | 50.00% | 0.01% |
| Jan. 15, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 1202 | $83.93 | 10,726.0000 | 121,997,348 | 10.08% | 0.00% |
| Jan. 15, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 1043 | $85.29 | 9,683.0000 | 121,997,348 | 9.72% | 0.00% |
| Jan. 15, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 966 | $86.26 | 8,717.0000 | 121,997,348 | 9.98% | 0.00% |
| Jan. 15, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 1136 | $82.89 | 11,928.0000 | 121,997,348 | 8.70% | 0.00% |
| Jan. 15, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 215 | $81.53 | 13,064.0000 | 121,997,348 | 1.62% | 0.00% |
| Jan. 15, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 146 | $80.46 | 13,279.0000 | 121,997,348 | 1.09% | 0.00% |
| Jan. 15, 2025 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | M | Common Stock | 6250 | $22.70 | 13,425.0000 | 121,997,348 | 87.11% | 0.01% |
| Sept. 17, 2024 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 4308 | $116.62 | 7,431.0000 | 97,157,690 | 36.70% | 0.00% |
| Sept. 17, 2024 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 1445 | $115.32 | 11,739.0000 | 97,157,690 | 10.96% | 0.00% |
| Sept. 17, 2024 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 241 | $114.64 | 13,184.0000 | 97,157,690 | 1.80% | 0.00% |
| Sept. 17, 2024 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | M | Common Stock | 6250 | $22.70 | 13,425.0000 | 97,157,690 | 87.11% | 0.01% |
| Sept. 17, 2024 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | M | Stock Option (right to buy) | 6250 | $0.00 | 12,500.0000 | 97,157,690 | 33.33% | 0.01% |
| Sept. 17, 2024 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | S | Common Stock | 256 | $117.51 | 7,175.0000 | 97,157,690 | 3.45% | 0.00% |
| June 6, 2024 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | A | Stock Option (right to buy) | 7250 | $0.00 | 7,250.0000 | 97,157,690 | 9999.99% | 0.01% |
| June 6, 2024 | Vaxcyte, Inc. | $PCVX | Loxam Teri | Director | A | Common Stock | 1550 | $0.00 | 7,175.0000 | 97,157,690 | 27.56% | 0.00% |
| March 1, 2024 | COMPASS Pathways plc | $CMPS | Loxam Teri | Chief Financial Officer | A | Ordinary Shares | 62718 | $0.00 | 62,718.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | COMPASS Pathways plc | $CMPS | Loxam Teri | Chief Financial Officer | A | Share Option (Right to Buy) | 117643 | $0.00 | 117,643.0000 | 0 | 9999.99% | 0.00% |